We are live on ! Find out more
GF

Gabelli Funds Portfolio holdings

AUM $14.8B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+9.25%
1 Year Est. Return
+32.24%
3 Year Est. Return
+88.06%
5 Year Est. Return
+130.29%
10 Year Est. Return
+486.58%
AUM
$14.1B
AUM Growth
+$963M
Cap. Flow
-$36.3M
Cap. Flow %
-0.26%
Top 10 Hldgs %
12.86%
Holding
1,287
New
192
Increased
280
Reduced
411
Closed
65

Top Buys

Rank Stock Value
1
SWTX
SpringWorks Therapeutics
SWTX
+$28.6M
2
BPMC
Blueprint Medicines
BPMC
+$21.9M
3
SKX
Skechers
SKX
+$16.9M
4
FARO
Faro Technologies
FARO
+$14M
5
DNB
Dun & Bradstreet
DNB
+$13M

Top Sells

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$43M
2
BECN
Beacon Roofing Supply, Inc.
BECN
+$20.6M
3
DFS
Discover Financial Services
DFS
+$18M
4
FNA
Paragon 28, Inc.
FNA
+$16.8M
5
NEM icon
Newmont
NEM
+$16.2M

Sector Composition

Rank Sector Weight
1 Industrials 20.94%
2 Financials 12.8%
3 Communication Services 10.31%
4 Technology 10.08%
5 Utilities 9.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALGN icon
1076
Align Technology
ALGN
$12B
$265K ﹤0.01%
1,400
– –
AXTA icon
1077
Axalta
AXTA
$7.01B
$261K ﹤0.01%
8,800
– –
MGNI icon
1078
Magnite
MGNI
$2.65B
$261K ﹤0.01%
10,820
– –
AIV
1079
Aimco
AIV
$380M
$260K ﹤0.01%
30,000
– –
HPQ icon
1080
HP
HPQ
$23.5B
$257K ﹤0.01%
10,500
– –
EMBJ
1081
Embraer S.A. ADS
EMBJ
$11.6B
$256K ﹤0.01%
4,500
– –
WAY
1082
Waystar Holding Corp
WAY
$4.32B
$255K ﹤0.01%
6,250
-1,650
-21% -$63.6K
LRCX icon
1083
Lam Research
LRCX
$382B
$253K ﹤0.01%
+2,600
New +$206K
J icon
1084
Jacobs Solutions
J
$15.9B
$250K ﹤0.01%
1,900
-120
-6% -$14.8K
TRUP icon
1085
Trupanion
TRUP
$1.05B
$249K ﹤0.01%
+4,500
New +$199K
CLAR icon
1086
Clarus
CLAR
$125M
$243K ﹤0.01%
70,000
+10,000
+17% +$33.9K
MGPI icon
1087
MGP Ingredients
MGPI
$378M
$240K ﹤0.01%
8,000
– –
IDT icon
1088
IDT Corp
IDT
$1.6B
$239K ﹤0.01%
+3,500
New +$201K
BKHA
1089
Black Hawk Acquisition Corp
BKHA
$50.3M
$239K ﹤0.01%
22,481
– –
CEPT
1090
DELISTED
Cantor Equity Partners II
CEPT
$238K ﹤0.01%
+21,600
New +$244K
MATV icon
1091
Mativ Holdings
MATV
$448M
$233K ﹤0.01%
34,200
-3,800
-10% -$21.9K
THS
1092
DELISTED
Treehouse Foods
THS
$233K ﹤0.01%
12,000
-20,500
-63% -$459K
SHOO icon
1093
Steven Madden
SHOO
$3.12B
$228K ﹤0.01%
9,500
– –
ARQ icon
1094
Arq
ARQ
$86.7M
$228K ﹤0.01%
42,400
+1,000
+2% +$4.38K
OPK icon
1095
Opko Health
OPK
$921M
$224K ﹤0.01%
170,000
– –
VYX icon
1096
NCR Voyix
VYX
$1.06B
$222K ﹤0.01%
+18,954
New +$192K
DWSN icon
1097
Dawson Geophysical
DWSN
$155M
$218K ﹤0.01%
149,200
– –
TSLA icon
1098
Tesla
TSLA
$1.24T
$213K ﹤0.01%
+672
New +$202K
CLF icon
1099
Cleveland-Cliffs
CLF
$6.81B
$213K ﹤0.01%
28,000
– –
GRMN
1100
Garmin
GRMN
$46.9B
$209K ﹤0.01%
1,000
– –
42 43
44
45 46

Similar funds

FCAS
First Command Advisory Services Fort Worth, Texas $14.8B AUM 18.11% 1-Year Est. Return
BGC
Beutel, Goodman & Co Toronto, Ontario, Canada $14.8B AUM 15.12% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
CCM
Cantillon Capital Management New York $15.1B AUM 23.54% 1-Year Est. Return
AT
AMF Tjänstepension Stockholm, Sweden $15.1B AUM 30.1% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $15.1B AUM 26.53% 1-Year Est. Return

Gabelli Funds's Q2 2025 Portfolio in Review

As of Q2 2025, Gabelli Funds held 1,287 positions worth $14.1B, up 7.3% from $13.1B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Gabelli Funds's Q2 2025 filing shows 192 new, 280 increased, 411 reduced and 65 closed positions. Its largest new stake was Blueprint Medicines: 211,169 shares worth $27.1M. The largest sale was Intra-Cellular Therapies Inc., an estimated $43M.

By sector, the portfolio is most concentrated in Industrials at 21% of assets, up from 21% a quarter earlier, followed by Financials and Communication Services.

  • Gabelli Funds's largest Q2 2025 buy was Blueprint Medicines: 211,169 shares worth $27.1M.
  • Gabelli Funds added most to SpringWorks Therapeutics in Q2 2025, an estimated $28.6M increase.
  • Gabelli Funds's biggest Q2 2025 reduction was Newmont, cutting an estimated $16.2M.
  • Gabelli Funds fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $43M.
  • Gabelli Funds's ten largest holdings make up 13% of its $14.1B portfolio in Q2 2025.
  • Gabelli Funds opened 192 new positions and closed 65 in Q2 2025.
  • Gabelli Funds's portfolio value rose 7.3% quarter-over-quarter to $14.1B.

Based on Gabelli Funds's 13F filing for Q2 2025, filed 13 Aug 2025.